Biosafety Testing

Biosafety for Vaccine Development or Production

CBI can perform in-vitro Biosafety testing on samples for bulk release, cell banking, and vaccine production. CBI will supply a GLP report along with protocols and SOPs for vaccine or product files. CBI uses validated assays to enable FDA submission of results.


    In vitro Safety
  • PERT Assay
  • Mycoplasma Testing
  • Adventitious Agents
  • Sterility
  • Endotoxin, Other toxins
  • Residual DNA/Protein
  • Neutralization Assay
  • Plaque Assay (potency)
  • PRN Assay
  • ELISA

Mycoplasma Plus PCR testing of
samples run on an agarose gel:
Lane 1. 50-2000 bp mw
Lane 2. Internal control
Lane 3. Positive control
Lane 4. IC and PC
Lane 5. Sample (MIC01-00020)
Lane 6. Sample (MIC01-00020) w/ IC
Lane 7. No template control
Lane 8. 1 kb ladder




Amino Acid Analysis Price List
Amino Acid Analysis Order Form
Request a Quotation



Commonwealth Biotechnologies, Inc.
601 Biotech Drive, Richmond, VA 23235
800-735-9224 (800-RELY-CBI) FAX: 804-648-2641
email: [email protected]
Peptide Synthesis | Protein Sequencing | Amino Acid Analysis | ELISA Development | Spectroscopies | Mass Spectroscopy | Oligonucleotide Synthesis | Vaccine Development | Proteomics | Antibody Services | Calorimetry | DNA Sequencing | Gene Synthesis | Genetic Testing | Molecular Biology | TaqMan and PCR Assays | Drug Development | Microbiology | Bio-Defense | Forms | Contact Us | CBI Capabilities | Corporate Officers | Senior Scientific Staff | Sales and Marketing | News | Site Map